Fmr LLC Eye Point Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,870 shares of EYPT stock, worth $21,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,870

Previous 32,409 94.23%

Holding current value

$21,748

Previous $669,000 97.61%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$8.16 - $22.89 $249,198 - $699,037	-30,539 Reduced 94.23%	1,870 $16,000
Q1 2024 May 13, 2024	SELL	$19.93 - $29.71 $1,514 - $2,257	-76 Reduced 0.23%	32,409 $669,000
Q4 2023 Feb 13, 2024	BUY	$5.71 - $24.13 $171,802 - $726,023	30,088 Added 1255.24%	32,485 $750,000
Q3 2023 Nov 13, 2023	BUY	$7.99 - $15.36 $5,744 - $11,043	719 Added 42.85%	2,397 $19,000
Q2 2023 Aug 11, 2023	BUY	$3.03 - $9.0 $2,096 - $6,228	692 Added 70.18%	1,678 $14,000
Q1 2023 May 11, 2023	SELL	$2.28 - $5.04 $3,593 - $7,943	-1,576 Reduced 61.51%	986 $2,000
Q4 2022 Feb 13, 2023	BUY	$2.37 - $7.2 $5,908 - $17,949	2,493 Added 3613.04%	2,562 $8,000
Q3 2022 Nov 10, 2022	BUY	$6.96 - $11.12 $208 - $333	30 Added 76.92%	69 $1,000
Q2 2022 Aug 12, 2022	SELL	$7.25 - $12.71 $1.32 Million - $2.32 Million	-182,321 Reduced 99.98%	39 $0
Q1 2022 May 13, 2022	SELL	$8.67 - $14.11 $1.89 Million - $3.07 Million	-217,640 Reduced 54.41%	182,360 $2.22 Million
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $4.07 Million - $7.36 Million	399,996 Added 9999900.0%	400,000 $4.9 Million
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $30 - $46	4 New	4 $0

Others Institutions Holding EYPT

# of Institutions

156

Shares Held

57.5M

Call Options Held

224K

Put Options Held

1.41M

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $396M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account